CEP55 promotes pancreatic cancer proliferation, migration, and invasion in vitro and in vivo by activating the NF-κB signaling pathway and the PI3K/AKT signaling pathway. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.